Detection of Microplastics in Human Saphenous Vein Tissue Using μFtir: A Pilot Study

February 1, 2023 | PLOS ONE

READ THE REPORT >>

In 2019, pollution was reported as responsible for approximately 9 million premature deaths, with air pollution (both household and ambient air pollution) being responsible for over 70% [1]. There is also a growing body of data that links environmental pollution, particularly PM2.5 levels, with poor cardiovascular outcomes [for review: [2]). The precise composition of particulate matter in the PM2.5 or PM10 category is not known. Microplastics (MPs) are attracting interest as an emerging contaminant of concern that are present in these fractions. MPs are particles of synthetic polymers in the micro size range and while an international consensus on size range has not been reached, the typical range is between 1 μm and 5 mm [3]. MPs have been identified in all environmental compartments [46] food, drinking water [7,8], and more recently in human samples including stool [9], blood [10], cadaver lung [11], lung [12] and colon [13]. The biological impacts of MP exposure investigations using human cell and tissue approaches have started to be characterised; with inflammatory and oxidative stress type responses reported (for review: [14]). In a pilot study using blood taken from two healthy individuals, toxic effects of polyethylene (PE) beads, sizes 10–45 μm, with a 48-h exposure of 25–500 μg/mL, were observed to cause increased level of genomic instability, as evidenced by increased micronucleation, nucleoplasmic bridge formation and nuclear bud formation in human peripheral blood lymphocytes [15]. Aside from such cell and tissue culture studies, the clinical implications of MPs within the human body have not yet been determined. Evidence is emerging however, that high MP levels are associated with inflammatory disorders, specifically bowel disease [16].

Saphenous vein autografts are widely used as conduits in coronary artery bypass graft (CABG) procedures aimed at diverting blood around narrowed or blocked coronary arteries to restore blood supply to the heart in patients with coronary heart disease [17]. However, 40–50% of CABG procedures ultimately fail after 10 years due to a variety of factors [18]. Importantly, no published studies have examined any potential link between environmental MP exposure and CABG outcomes. A key first step is, therefore, to assess MP infiltration and composition in vascular conduits. Equally importantly, no published studies have examined whether MPs can infiltrate and or cross any biological barrier, including blood vessels. This study, therefore, aims to identify MP particles present in digested human saphenous vein tissue samples, while also accounting for procedural blank contamination. Any particles isolated from vein tissue have been chemically characterised using μFTIR spectroscopy.

 The full study is available here to view or download (PDF)

Previous
Previous

The Minderoo-Monaco Commission on Plastics and Human Health

Next
Next

Microplastics Occurrence, Health Effects, and Mitigation Policies: An Evidence Review for the California State Legislature